HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.

7th Edition of Global Conference on

Addiction Medicine, Behavioral Health and Psychiatry

October 19-21, 2026 | Boston, Massachusetts, USA

GAB 2026

Genetic decoupling and global regulatory failure in diseases of agency

Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2026 - Denis Larrivee
University of Navarra, Spain
Title : Genetic decoupling and global regulatory failure in diseases of agency

Abstract:

Neural mechanisms for self regulation feature prominently in studies of addiction, which is characterized by the inability to resist compulsive behavior. Such mechanisms entail not just top down processes involved in the execution of decision making events, but also the neural representation of the self/agent, generally regarded as the source of decision making capacity. Impairments of this representation can be expected to weaken the ability to enlist capacities for self regulation. Several cognitive diseases exhibit self recognition dysfunctions, suggesting that their study might reveal factors leading to self- representation impairments. Genetic studies, however, have been unable to identify molecular factors contributing to the impairments. Whole genome studies of diseases like schizophrenia, for example, have thus far failed to identify gene candidates exerting more than a marginal influence on behavioral symptoms. Affected single nuclear polymorphisms (SNPs), for example, number well above 12,000 indicating likely pool sizes of risk alleles running into the thousands. The indiscriminate and massive number of affected alleles seen in these studies implicates a higher order, organizational and regulatory impairment, rather than one involving specific genetic factors, which affects self- recognition and the ability to execute actions. Such a substrate is likely to be embedded within the interactive properties of large cell clusters such as those comprising neural circuits or even large-scale networks of the brain. The genetic findings thus suggest the existence of a process of decoupling regulation from genetic oversight to one involving a systemic and top down supracellular organization exerting regulatory control. Consistent with this interpretation, bodily informed, sensoria driven input are known to shape the synaptic architecture of the brain, thus implicating genetic decoupling and a shift to top down regulation. The inability to attribute actions to the self seen in these diseases thus also suggests a failure in how sensorial input from the body drives the formation of a global regulatory structure. Several leading proposals that link the sensorial representation of the body to the self/agent could offer a model for investigating the etiology of these diseases and will be discussed in this talk.

 

Biography:

Dr. Denis Larrivee is a visiting scholar at the Mind and Brain Institute, University of Navarra Medical School and Loyola University, Chicago. He has held professorships at the Weill Cornell University Medical College, NYC, and Purdue University, Indiana. A former fellow at Yale University's Medical School, Dr. Larrivee received the Association for Research in Vision and Ophthalmology's first place award for studies on photoreceptor degenerative and developmental mechanisms. He maintains an active interest in medical imaging technology and recently published an edited volume on current advances in magnetic resonance imaging. He is the editor of six additional texts on clinical neuroscience and neurotechnology and is an editorial board member of the Annals of Neurology and Neurological Sciences (USA) and EC Neurology (UK). Dr Larrivee is the lead author of more than one hundred papers and book chapters in such varied journals/venues as IEEE Xplore, the Journal of Neuroscience, Frontiers Human Neuroscience, and the Journal of Religion and Mental Health, including a recent article in the Journal of Responsible Innovation on the integration of ethics in medical neurotechnology design. In 2018, he was a finalist for the international Joseph Ratzinger Expanded Reason award sponsored by the Francis Vittorio University of Madrid. He is currently a member of the USA based IEEE BRAIN Task Force on value based design of medical neurotechnologies.

Watsapp